Jean-Pierre Lindenmayer

New York University — United States

Medicine · Health Sciences

34h-index5.3kcitations49works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Schizophrenia research and treatment(40), Bipolar Disorder and Treatment(14), Mental Health and Psychiatry(7), Functional Brain Connectivity Studies(6), Obsessive-Compulsive Spectrum Disorders(6)

Publications49 total

A Modified Delphi Consensus Study of the Screening, Diagnosis, and Treatment of Tardive Dyskinesia
The Journal of Clinical Psychiatry·2020· 26 cited
The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research
Schizophrenia·2020· 340 citedOpen Access
Cognitive remediation for schizophrenia: An expert working group white paper on core techniques
Schizophrenia Research·2019· 238 citedOpen Access
Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia
The Journal of Clinical Psychiatry·2019· 313 cited
77 Long-term Valbenazine Treatment in Patients with Schizophrenia/Schizoaffective Disorder or Mood Disorder and Tardive Dyskinesia
CNS Spectrums·2019· 2 citedOpen Access
Validation of the MUSIC Model of Motivation Inventory for use with cognitive training for schizophrenia spectrum disorders: A multinational study
Schizophrenia Research·2018· 11 citedOpen Access
The NIMH Research Domain Criteria Initiative and Comorbidity in Schizophrenia: Research Implications
Psychiatric Annals·2018· 2 cited
Do cognitive deficits predict negative emotionality and aggression in schizophrenia?
Psychiatry Research·2017· 55 cited
COMT genotype and response to cognitive remediation in schizophrenia
Schizophrenia Research·2015· 38 citedOpen Access
Schizophrenia with Obsessive-Compulsive Symptoms: Clinical and Conceptual Issues
Psychiatric Annals·2013· 4 cited
Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
Schizophrenia Research·2013· 52 cited
Erratum: Pimozide Augmentation of Clozapine Inpatients with Schizophrenia and Schizoaffective Disorder Unresponsive to Clozapine Monotherapy
Neuropsychopharmacology·2011Open Access
Pimozide Augmentation of Clozapine Inpatients with Schizophrenia and Schizoaffective Disorder Unresponsive to Clozapine Monotherapy
Neuropsychopharmacology·2011· 38 citedOpen Access
Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: A randomized five month study
Schizophrenia Research·2010· 35 cited
Long-acting injectable antipsychotics: focus on olanzapine pamoate
Neuropsychiatric Disease and Treatment·2010· 68 citedOpen Access
Neuroleptic Malignant Syndrome in Children and Adolescents on Atypical Antipsychotic Medication: A Review
Journal of Child and Adolescent Psychopharmacology·2009· 71 citedOpen Access
Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior Response
The Journal of Clinical Psychiatry·2009· 161 cited
Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder
Schizophrenia Research·2009· 106 cited
Normal Pressure Hydrocephalus Presenting as Othello Syndrome: Case Presentation and Review of the Literature
American Journal of Psychiatry·2008· 78 cited
Standard and Higher Dose of Olanzapine in Patients With Schizophrenia or Schizoaffective Disorder
Journal of Clinical Psychopharmacology·2008· 95 cited
page 1 of 3Next →

Frequent Co-authors

Jan Volavka(21), Leslie Citrome(20), Pál Czobor(19), Jeffrey A. Lieberman(17), Brian Sheitman(16), Joseph P. McEvoy(16), Miranda Chakos(10), Thomas B. Cooper(10), Nigel Bark(5), Matthew J. Hoptman(4), Michal Kunz(4), Stephen R. Marder(4), Adel Iskander(4), H. Gerbaldo(4), Robert M. Bilder(3), John M. Kane(3), Karen A. Nolan(3), Bruce J. Kinon(3), Virginia L. Stauffer(3), Robert C. Smith(3)